Proceedings of the National Academy of Sciences published the study.
Here are four highlights:
1. The study focused on protein interleukin 37, examining the its effect on physiopathology spinal cord injury in mouse models.
2. The mice maintained some of their mobility when researchers immediately applied IL 37 following spinal cord injury.
3. IL 37 suppressed the inflammatory response, which causes spinal tissue degeneration and functional disabilities.
4. The study’s findings may prove helpful for alternative therapeutic treatments for acute spinal cord injury.
More articles on spine:
5 key notes on ocular radiation exposure during minimally invasive spine surgery
Dr. Fred Sweet serves visiting professor to University of Pennsylvania — 5 observations
The race to the White House: Spine surgeons weigh in on candidates’ healthcare strategy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.